Whatever kind of life sciences company you are, it’s important to get your message out there and communicate your work to the right people. Media coverage can be an excellent way to do that, but getting interest from the top publications can be harder than it looks.
In August, we hosted the One Nucleus ‘BioWednesday’ event, inviting four leading life sciences journalists to share their industry insights, hearing from Clive Cookson, Financial Times; Amber Tong, Endpoints; Lucie Ellis, In Vivo; and Sabah Meddings, Sunday Times. Here, we share their top tips on how to create great stories and secure coverage.
Congratulations to our clients Fstar, Hookipa and Microbiotica, each pioneering disruptive technologies for the development of tomorrow’s therapeutics. They have announced bio-dollar deals collectively worth up to ~$1.4 billion.
MiFID II. An acronym that instils a broad set of emotions across the City of London, ranging from blind panic in some quarters to mild indifference in others. This widely quoted but little understood abbreviation of the second Markets in Financial Instruments Directive is already having an effect across the industry. However, the fact that each financial institution is interpreting the regulations in different ways show the level of confusion, with some continuing as if nothing has changed, whilst others feel that sending a piece of research to a PR is an invitation to buy or sell shares.
Instinctif Partners is pleased to announce that Sue Charles, Managing Partner of its Life Sciences Practice and 30 year veteran of the biotech industry has been elected to the Board of Directors of the UK BioIndustry Association (BIA).
The results of the voting were announced at the BIA AGM yesterday, alongside four other new Board members, namely Dr Jane Dancer (F-star), Prof Jackie Hunter (Benovelent AI), Dr Kyriacos Mitrophanous (Oxford BioMedica) and Keith Thompson (Cell and Gene Therapy Catapult).
For over 10 years Instinctif Partners has supported Jeans for Genes Day which is the annual fundraising campaign for Genetic Disorders UK, the national charity that supports individuals and families affected by a genetic disorder.
On Friday 22 September we once again left our suits at home and wore our jeans to help to raise money for this great cause – helping to fund the vital care and support services that transform the lives of 1-in-25 children who have inherited a genetic disorder that makes their life very difficult.
The UK Government’s Industrial Strategy Green Paper has named the life sciences as a key strategic sector. Today, the findings of an independent sector-led review into the £64 billion life sciences sector was unveiled, which will inform the basis of UK Government work with the sector towards a sector deal in the coming months. This report comes at a critical time as the UK is defining its post Brexit strategies.
The Life Science Industrial Strategy (LSIS) report to Government lays out a consensus of the opportunity across the life science ecosystem in the UK. Its development was led by Professor Sir John Bell and the Life Sciences Industrial Strategy Board which was established in 2016.
Instinctif Partners was delighted to be on the Biotech and Money Advisory Board and 2017 Awards executive judging panel in June - looking forward to the Awards Gala Dinner on the 14 September at the Gibson Hall, London.
Good luck to all the finalists, including our clients Abzena, Apollo Therapeutics, Astex Pharmaceuticals, Auspherix, Cell Medica, Clinigen, Congenica, Crescendo Biologics, F-Star, Microbiotica, Mission Therapeutics and SkinBioTherapeutics.
It’s not too late to vote - online voting, which contributes to 50% of the final vote is open here.
Britain might not have produced any large new biotech enterprises like America’s Amgen, Biogen or Gilead, but there are notable successes for which the country should be proud. It is against these which entrepreneurs and managers of today’s biotech companies should set their ambitions and measure their success.
It’s all too easy to look to failures – of markets, Government interventions and companies - indeed this was the theme in the book Science, the State and the City: Britain's Struggle to Succeed in Biotechnology by Geoffrey Owen and Michael M. Hopkins published last year. Based on a rich analysis of the UK’s last 40 years of investment in biotech, they concluded that the UK has not succeeded in creating Bellweathers – as measured in terms of UK stock market valuations of therapeutic biotechs.
20 years ago Instinctif Partner’s Sue Charles introduced a now famous sheep to the world
In February 1997, via a publication in Nature, scientists in Scotland announced the birth of the world's first successfully cloned mammal, and it was Instinctif Partners Managing Partner Sue Charles, who led the PR effort to introduce ‘Dolly the sheep’ to the world.
Instinctif Partners has been awarded silver in the large consultancy category by PR Week for Best Places to Work
These awards recognise those UK-based consultancies and in-house comms departments that go the extra mile to offer a superb working environment and progressive practices in the workplace, whether it's around training, mentoring, pay, maternity and paternity issues, or a host of other areas.
The International Communications Consultancy Organisation (ICCO) has awarded the accolade of Regional Independent Consultancy of the Year (EMEA) to Instinctif Partners at an awards ceremony in London on Thursday 1 December 2016.
14-20 November 2016 - World Antibiotic Awareness Week aims to increase awareness of global antibiotic resistance and to encourage initiatives to avoid the further emergence and spread of antibiotic resistance.
European Antibiotic Awareness Day comes at the end of the week, on 18 November and is an annual European public health initiative to raise awareness about the threat to public health of antibiotic resistance and the importance of prudent antibiotic use.
In a continued run of award success, Instinctif Partners has been named UK PR Consultancy of the Year at the 2016 Corporate and Financial Awards. Its work for its clients was also recognised in five categories. The Corporate and Financial Awards recognise and celebrate excellence in all aspects of business communication.
For over 10 years Instinctif Partners has supported Jeans for Genes Day. On Friday 23 September we will once again be leaving our suits at home and wearing jeans to help to raise money for this great cause – helping to fund the vital care and support services that transform the lives of 1 in 25 children also inherit a genetic disorder that makes their life very difficult.
Instinctif Partners was delighted to be on the Biotech and Money Advisory Board and 2016 Awards executive judging panel in June - looking forward to the Awards Gala Dinner on the 6 September at the Gibson Hall, London.
Good luck to all the finalists, including our clients Abcam, Abzena, Auspherix, Autifony, Clinigen, Immunocore, Novabiotics and Puridify.
On 23 June the UK voted in a referendum to leave the EU. As this process and its ramifications unfold over the coming months and years, Instinctif Partners is helping its clients to steer their businesses successfully through this period of change and uncertainty.
On Tuesday, 21 June 2016 Instinctif Partners hosted the Biotech and the City Summer event, the main mid-year networking event for Biotech and Money community members. The evening was a great success and served as an informal forum for senior executives to come together, network and enjoy a relaxed evening of great networking with their peers.